DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Headset-Type EEG Measurement Device and Real-Time Analysis Software Released by Domestic Manufacturer
Tokai Optical Co., Ltd. will release the “TOKAI Orb Pz” headset-type EEG measurement device and the real-time EEG analysis software “OrbView REAL” on December 22, 2025, as the fifth product in its series of basic medical research equipment. The TOKAI Orb Pz is a headset-type EEG device featuring balanced electrode placement over the frontal, parietal, and occipital regions. It inherits the core performance of existing TOKAI Orb models while adding electrodes to the parietal P-line (P3, Pz, P4) alongside the frontal and occipital regions, enabling it to meet a broader range of research needs. OrbView REAL is software that enables real-time monitoring, recording, and analysis of evoked brainwaves, event-related potentials, and more.
The addition of TOKAI Orb Pz to the TOKAI Orb series expands headset options tailored to specific EEG research objectives. Furthermore, the real-time analysis software not only enhances monitoring accuracy during EEG recording but also opens new possibilities for utilizing EEG information in real time.
Through providing the TOKAI Orb headset-type EEG measurement device, Tokai Optical Co., Ltd. will advance co-creation with researchers at universities and research institutions, contributing to the development of this academic field and the promotion of industrial applications in brain science.
Copenhagen-based EvodiaBio raises €6 million to scale fermentation-based flavour technology
Danish flavour company EvodiaBio has raised €6 million (DKK 45 million) in a new funding round to accelerate growth in existing markets and support their expansion into the asian market.
The round was led by the American investment firm RA Capital Management’s Planetary Health Fund and joined by other new investors Wild Radicals and Francis Family Funds, as well as existing investors EIFO, Ananke Ventures, Newtree Impact, PINC (Paulig), Jarne Elleholm (co-founder and Chairman of the Board), Sotirios Kampranis (co-founder), Camilla Kloss Fenneberg (CEO), and three board members: Flemming Besenbacher, Anne Cabotin, and Andreas Fibig.
Today’s funding announcement, follows last year’s €7 million raise – as reported by EU-Startups.
SleepTech Global Brand Presents New Approach to Treatment-Resistant Hypertension Symposium Held on Hypertension Caused by Sleep Apnea Syndrome
ResMed Inc. (Headquarters: Chiyoda-ku, Tokyo), a manufacturer and distributor of medical devices for sleep apnea syndrome (SAS) and chronic respiratory diseases (such as COPD), held a symposium titled “Sleep Apnea and Hypertension” at the 47th Annual Meeting of the Japanese Society of Hypertension, held at KABUTO ONE on Friday, October 17.
This symposium focused on the relationship between “treatment-resistant hypertension[1]”—a pressing issue in Japanese hypertension management where blood pressure remains uncontrolled despite basic treatment—and sleep apnea syndrome. Physicians active in clinical practice delivered presentations on the newly revised ‘Hypertension Management and Treatment Guidelines 2025’ (first updated in six years) and nocturnal hypertension.
Beyond Wearables: How Radar Technology is Revolutionizing Elderly Sleep Monitoring
Radar holds the potential to change the way we look after elderly people, with new radar-based sleep monitors offering a way to rethink the way elderly people are monitored both in elder care facilities and in their own homes. Traditional monitoring techniques have significant drawbacks when it comes to elder care: for example, cameras have significant privacy, security and compliance concerns, and wearables have practical issues both in elder care facilities and the home.
By contrast, radar can help physicians monitor how elderly people are sleeping through the night, offering important insights into their overall health, while also integrating with other technology, so that, for example, lights and televisions can turn off when an elderly patient goes to sleep. Perhaps most importantly, the discreet, privacy-preserving technology holds the promise that elderly people can live independently for longer.
New Microorganism Discovered That Concentrates Copper to “Ore Grade” Levels Mechanism of Copper Concentration by Iron-Oxidizing Bacteria Elucidated, Raising Hopes for Bio-Mining
Professor Seiji Mitsunobu and graduate student Kazuya Tanimoto from Ehime University's Graduate School of Agriculture, in collaboration with RIKEN, the Japan Atomic Energy Agency, and Kyushu University's Graduate School of Science, have successfully isolated a novel iron-oxidizing bacterium capable of concentrating and immobilizing copper to “ore-grade” levels. They elucidated the mechanism by which this bacterium's potent iron-oxidizing activity drives high copper concentration. This achievement represents a significant result that could lead to the development of valuable metal recovery (biomineralization) and environmental remediation technologies utilizing microorganisms.
Furthermore, these findings were published in the international scientific journal Environmental Microbiology by Wiley, USA, on November 30, 2025.
French Fermentation Firm Bags $6M to Scale Up Upcycled Cocoa Alternatives
French startup Green Spot Technologies has raised €5M ($5.8M) to expand production of its waste-derived fermented ingredients, including cocoa alternatives under new brand Milatea.
As the hunt for cocoa alternatives reaches a fever pitch, one startup is turning to food waste to solve several environmental problems at once.
Based in Toulouse, Green Spot Technologies upcycles commercial food waste – such as spent brewer’s grain, tomato skins, and wine grape marc – by fermenting them into nutrient-dense, high-fibre powders for a variety of applications.
Now, the startup has secured €5M ($5.8M) in new funding to expand its production and portfolio. The round combined equity and bank loans and was led by Team for the Planet, with additional support from the European Innovation Council, EIT Food, and new angel investors.
Green Spot Technologies will use the capital to scale up its capacity from 100 to 1,000 tonnes per year, and launch a new ingredients brand called Milatea.
Germany’s Bluu Goes Beyond Cultivated Seafood with Move Into Health & Beauty
German startup Bluu has expanded its salmon cell culture technology to skincare and health innovations, adding to its existing cultivated seafood line.
Hamburg-based Bluu has taken a “salmon leap of opportunities” with the expansion of its cell-cultivated fish platform.
The company, known for its cultured seafood brand, is diversifying its business into the health and beauty markets to accelerate the scaling of cultivated marine cell production in Europe amid its efforts to navigate the regulatory red tape around novel foods in the region.
“We can now outperform nature in creating something perfectly natural. At a cellular level, our cultivated fish products are no different from anything derived from wild-caught or farmed salmon – but, unlike those, they are perfectly traceable and sustainable, without artificial flavours or antibiotics, and without any contamination by microplastics,” said Bluu co-founder and CEO Sebastian Rakers.
“This level of purity combined with reliable sourcing has proven to be very interesting to our partners in beauty and health.”
High-performance duvet incorporating graphene, a carbon fiber with high thermal conductivity
EMOOR Co., Ltd. (Tachikawa City, Tokyo; President: Koji Takahashi; hereinafter EMOOR), which operates the health furniture brand EMOOR offering “sleeping, sitting, and folding that fits your body,” began sales of its “Graphene-filled Quilt” on October 23, 2025.
Smart Skincare Trends: Using AI Technology to Understand Your Skin Better
Finding the perfect skincare routine can feel like an endless game of trial and error. Even with countless products and expert advice, and beauty trends, many people still struggle to address their unique skin needs. Why? Traditional routines often rely on generic recommendations rather than insights tailored to individual skin concerns.
Fortunately, technology is stepping in to change the game. Artificial intelligence (AI) is making it possible to understand your skin in ways that were unimaginable just a few years ago. From analyzing facial concerns to suggesting personalized products, AI is helping people achieve healthier, glowing skin—faster and more effectively than ever before.
Mapping technology challenges the limits of sequence analysis Major pharmaceutical companies are preparing to identify new targets they cannot reach
The startup, launched out of CEO Kevin Parker’s grad school idyll during the COVID lockdowns, is primed to find new targets where Big Pharmas won’t dare.
Back in the old days of the early 2020s, using gene sequencing to find drug targets was a messy business.
“The traditional method was bulk sequencing—take an entire tissue, explode it all, measure the average,” Kevin Parker, the co-founder and CEO of Cartography Biosciences and recent BioSpace 40 Under 40 honoree, told BioSpace. But diseases like cancer are highly complex, potentially driven by a mutation in a cell that may make up just 1% of a tumor but carries a critical gene mutation that would make a great therapeutic target.
New wearable sensor tracks vitamin B6 levels in sweat
Vitamin B6, which is absorbed from a broad range of foods, helps bolster immune system function and neurotransmitters in the brain. But some patients with chronic conditions like diabetes might experience low concentrations of vitamin B6, leading to reduced mental and physical health function, with possible symptoms including irritability, depression, anemia, numbness or muscle twitching. Expensive blood draws are currently the only way to monitor B6 levels, but a team led by Huanyu "Larry" Cheng, the James L. Henderson, Jr. Memorial Associate Professor of Engineering Science and Mechanics at Penn State, has developed a new, non-invasive approach that could allow for continuous monitoring, even at home.
The researchers created an on-skin sensing platform to detect vitamin B6 in small concentrations of sweat, instead of relying on laboratory tests. The sensor can also detect glucose at a high sensitivity, allowing patients with diabetes to non-invasively monitor glucose and vitamin B6 simultaneously, Cheng said. The team published their approach in Composites Part B: Engineering.
Cascade Bio is set to revolutionize biomanufacturing with a significant new funding round aimed at enhancing enzyme-based processes.
Cascade Bio, an industrial biotechnology company focused on enzyme-based processes, has successfully raised $6 million to expedite the transition from petrochemicals to biomanufacturing. This funding comprises a $2.8 million seed round led by Endurance28, with contributions from Stray Dog Capital, 1Flourish, and existing investors Range Ventures, Ten VC, and Amplify.LA, alongside $3.2 million in nondilutive funding from the National Science Foundation (NSF) through its cell-free ideas lab program (CFIRE) and an SBIR Phase II grant. With this financial boost, Cascade aims to enhance the delivery of its innovative biocatalysts, providing industrial partners with high-performing enzymes that reduce costs and facilitate biobased production.
Cascade's technology focuses on utilizing cost-effective materials to extend the lifespan of costly enzymes significantly. The company has already worked on more than 30 different enzymes, achieving a 100% success rate in improving stability under challenging industrial conditions for over 20 paying customers. These early collaborations include partnerships with some of the largest companies in the chemical, flavor and fragrance, food ingredient, and pharmaceutical sectors, helping them integrate more biological processes into their manufacturing operations.
Program for Universal Stethoscope Regulatory Approval of Digital Biomarkers
AMI Corporation announces that it obtained regulatory approval on September 25, 2025, for its general-purpose cardiac sound analyzer program “Digital Biomarker DNP-HF,” which had been under development.
We will continue accelerating the research and development of medical devices and related services to realize a society where high-quality medical care can be accessed anytime, anywhere, by anyone, non-invasively, and in a short time.